Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tina Cheng

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|June 17, 2024
Imaging response to immune checkpoint inhibitors in patients with advanced melanoma: a retrospective observational cohort studyMehul Gupta, Igor Stukalin, Daniel E Meyers, et al.
The Oncologist|August 30, 2023
Adjuvant Systemic Therapies for Resected Stages III and IV Melanoma: A Multi-Center Retrospective Clinical StudyRodrigo Rigo, Philip Q Ding, Eugene Batuyong, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 21, 2006
Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3Lisa M Galli, Tiffany Barnes, Tina Cheng, et al.
JAMA Network Open|June 23, 2023
Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced MelanomaMehul Gupta, Igor Stukalin, Daniel Meyers, et al.
Cancer Medicine|August 4, 2022
Comparing the associations between host and tumor factors with survival outcomes with anti-PD-1 immunotherapy in metastatic melanomaKim Koczka, Rodrigo Rigo, Eugene Batuyong, et al.
American Journal of Clinical Oncology|August 8, 2012
Intermittent LHRH therapy in the management of castrate-resistant prostate cancer (CRPCa): results of a multi-institutional randomized prospective clinical trialMichael Organ, Lori Wood, Derek Wilke, et al.
Journal of the American Academy of Dermatology|March 21, 2026
Younger Age at Melanoma Diagnosis: A Survey Study of Indoor Tanning UseMeghan Mahoney, Annie Wu, Haocheng Li, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 13, 2009
A population-based study examining the effect of tyrosine kinase inhibitors on survival in metastatic renal cell carcinoma in Alberta and the role of nephrectomy prior to treatmentMark Warren, Peter M Venner, Scott North, et al.
Parasitology Research|May 23, 2018
A quick and simple benchtop vortex egg-disruption approach for the molecular diagnosis of Fasciola hepatica from ruminant faecal samplesNichola Eliza Davies Calvani, Tina Cheng, Christine Green, et al.
Current Oncology (Toronto, Ont.)|October 22, 2021
Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based AnalysisRodrigo Rigo, Jordan Doherty, Kim Koczka, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|June 17, 2024
Imaging response to immune checkpoint inhibitors in patients with advanced melanoma: a retrospective observational cohort studyMehul Gupta, Igor Stukalin, Daniel E Meyers, et al.
The Oncologist|August 30, 2023
Adjuvant Systemic Therapies for Resected Stages III and IV Melanoma: A Multi-Center Retrospective Clinical StudyRodrigo Rigo, Philip Q Ding, Eugene Batuyong, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 21, 2006
Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3Lisa M Galli, Tiffany Barnes, Tina Cheng, et al.
JAMA Network Open|June 23, 2023
Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced MelanomaMehul Gupta, Igor Stukalin, Daniel Meyers, et al.
Cancer Medicine|August 4, 2022
Comparing the associations between host and tumor factors with survival outcomes with anti-PD-1 immunotherapy in metastatic melanomaKim Koczka, Rodrigo Rigo, Eugene Batuyong, et al.
American Journal of Clinical Oncology|August 8, 2012
Intermittent LHRH therapy in the management of castrate-resistant prostate cancer (CRPCa): results of a multi-institutional randomized prospective clinical trialMichael Organ, Lori Wood, Derek Wilke, et al.
Journal of the American Academy of Dermatology|March 21, 2026
Younger Age at Melanoma Diagnosis: A Survey Study of Indoor Tanning UseMeghan Mahoney, Annie Wu, Haocheng Li, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 13, 2009
A population-based study examining the effect of tyrosine kinase inhibitors on survival in metastatic renal cell carcinoma in Alberta and the role of nephrectomy prior to treatmentMark Warren, Peter M Venner, Scott North, et al.
Parasitology Research|May 23, 2018
A quick and simple benchtop vortex egg-disruption approach for the molecular diagnosis of Fasciola hepatica from ruminant faecal samplesNichola Eliza Davies Calvani, Tina Cheng, Christine Green, et al.
Current Oncology (Toronto, Ont.)|October 22, 2021
Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based AnalysisRodrigo Rigo, Jordan Doherty, Kim Koczka, et al.
Pageof 7